Cappella Medical Devices Limited Announces New Data at Dedicated Bifurcation Lesion Conference

GALWAY, Ireland--(BUSINESS WIRE)--Cappella Medical Devices announced today that it is a co-sponsor of the first national conference dedicated specifically to coronary bifurcation disease being held in Birmingham, United Kingdom. The conference, called BLT (Bifurcation Lesion Treatment) 2011, is focused on discussing the challenges, limitations, and opportunities for treating this disease which occurs in 20-30% of all percutaneous coronary interventions.